Accelerate Diagnostics Free Cash Flow 2010-2024 | AXDX
Accelerate Diagnostics free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Accelerate Diagnostics Annual Free Cash Flow | |
|---|---|
| 2024 | -24.70 |
| 2023 | -41.23 |
| 2022 | -49.28 |
| 2021 | -47.93 |
| 2020 | -51.76 |
| 2019 | -65.12 |
| 2018 | -68.75 |
| 2017 | -58.71 |
| 2016 | -55.82 |
| 2015 | -38.78 |
| 2014 | -20.72 |
| 2013 | -10.91 |
| 2012 | 0.00 |
| 2012 | -0.91 |
| 2011 | 0.37 |
| 2010 | -0.84 |
| 2009 | -0.30 |
| Accelerate Diagnostics Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | -24.70 |
| 2024-09-30 | -19.64 |
| 2024-06-30 | -16.55 |
| 2024-03-31 | -8.97 |
| 2023-12-31 | -41.23 |
| 2023-09-30 | -33.37 |
| 2023-06-30 | -24.36 |
| 2023-03-31 | -13.38 |
| 2022-12-31 | -49.28 |
| 2022-09-30 | -39.62 |
| 2022-06-30 | -26.05 |
| 2022-03-31 | -13.05 |
| 2021-12-31 | -47.93 |
| 2021-09-30 | -35.58 |
| 2021-06-30 | -22.96 |
| 2021-03-31 | -13.38 |
| 2020-12-31 | -51.76 |
| 2020-09-30 | -41.42 |
| 2020-06-30 | -28.04 |
| 2020-03-31 | -18.04 |
| 2019-12-31 | -65.12 |
| 2019-09-30 | -51.08 |
| 2019-06-30 | -33.64 |
| 2019-03-31 | -19.54 |
| 2018-12-31 | -68.75 |
| 2018-09-30 | -54.27 |
| 2018-06-30 | -36.12 |
| 2018-03-31 | -17.36 |
| 2017-12-31 | -58.71 |
| 2017-09-30 | -44.55 |
| 2017-06-30 | -29.73 |
| 2017-03-31 | -15.70 |
| 2016-12-31 | -55.82 |
| 2016-09-30 | -42.91 |
| 2016-06-30 | -30.17 |
| 2016-03-31 | -14.89 |
| 2015-12-31 | -38.78 |
| 2015-09-30 | -27.83 |
| 2015-06-30 | -18.52 |
| 2015-03-31 | -8.16 |
| 2014-12-31 | -20.72 |
| 2014-09-30 | -15.35 |
| 2014-06-30 | -8.53 |
| 2014-03-31 | -4.10 |
| 2013-12-31 | -10.91 |
| 2013-09-30 | -8.09 |
| 2013-06-30 | -5.07 |
| 2013-03-31 | -2.95 |
| 2012-12-31 | |
| 2012-10-31 | -1.09 |
| 2012-09-30 | -1.37 |
| 2012-07-31 | |
| 2012-06-30 | -1.35 |
| 2012-04-30 | -0.49 |
| 2012-03-31 | -0.21 |
| 2012-01-31 | -0.19 |
| 2011-10-31 | -0.10 |
| 2011-07-31 | |
| 2011-04-30 | 0.16 |
| 2011-01-31 | 0.22 |
| 2010-10-31 | -0.04 |
| 2010-07-31 | |
| 2010-04-30 | -0.92 |
| 2010-01-31 | -0.65 |
| 2009-10-31 | -0.30 |
| 2009-07-31 | |
| 2009-04-30 | -0.18 |
| 2009-01-31 | -0.15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.013B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||